SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001144204-08-002539
Filing Date
2008-01-16
Accepted
2008-01-16 14:09:08
Documents
5
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 v099694_10ka.htm 10-K/A 644883
2 v099694_ex31-1.htm EX-31.1 19799
3 v099694_ex31-2.htm EX-31.2 16973
4 v099694_ex32-1.htm EX-32.1 6943
5 v099694_ex32-2.htm EX-32.2 7423
  Complete submission text file 0001144204-08-002539.txt   697486
Mailing Address 1617 JFK BLVD ONE PENN CENTER PHILADELPHIA PA 19103
Business Address 1617 JFK BLVD #660 ONE PENN CENTER PHILADELPHIA PA 19104 2159880080
HEMISPHERX BIOPHARMA INC (Filer) CIK: 0000946644 (see all company filings)

IRS No.: 520845822 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K/A | Act: 34 | File No.: 001-13441 | Film No.: 08533126
SIC: 2836 Biological Products, (No Diagnostic Substances)